Scientists at the
are leading a major European clinical engineering project that should see human tissue grown from stem cells available for transplant in the next four years.
Scientists will develop the technology to target heart failure, diabetes, chronic ulcers and neurodegenerative diseases in particular.
The £17million project, funded by the European Commission and led by the
Professor David Williams, Director of the UK Centre For Tissue Engineering at the
“This is not really being achieved anywhere in the world yet, but this major new project will bring together a team, with critical mass, and a range of expertise from stem cell biology to bio-manufacturing processes, including ethics and business models.”
Tissue Engineering is an emerging technology that will provide therapies for wide-ranging diseases and chronic injuries. It involves taking human cells, such as stem cells, from blood or bone marrow and encouraging those cells to produce new tissue through the use of growth factors.
Researchers in
have been developing methods of growing a variety of tissue, including human arteries, from adult stem cells. Blood vessels grown in the laboratory could be used to replace furred up arteries in patients suffering from coronary heart disease.
UK productivity hindered by digital skills deficit – report
This is a bit of a nebulous subject. There are several sub-disciplines of 'digital skills' which all need different approaches. ...